Crysvita and Dupixent are also negotiating drug prices. It has been found that Chinese pharmaceutical company BeiGene Korea has entered into drug price negotiations with the NHIS for Brukinsa capsules 80mg sold domestically. When the NHIS drug price negotiation is completed, the drug will be covered through a report to the Health Insurance Policy Deliberation Committee of the Ministry of Health and Welfare. According to the industry on the 27th, The NHIS recently disclosed this fact on its website.

Since April 2019, The NHIS has been disclosing the drugs ordered by the Ministry of Health and Welfare to NHIS for drug price negotiations on its website for the public's right to know. According to the Minis